CoreCap Advisors’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.63K Buy
238
+236
+11,800% +$1.44K ﹤0.01% 2468
2026
Q1
$15 Hold
2
﹤0.01% 2912
2025
Q4
$19 Hold
2
﹤0.01% 2929
2025
Q3
$8 Buy
+2
New +$13 ﹤0.01% 2778

Other funds holding REPL

CoreCap Advisors's REPL Position: Q2 2026 in Review

CoreCap Advisors increased its Replimune Group (REPL) stake by 11,800% in Q2 2026, buying an estimated $1.44K and bringing the position to 238 shares worth $2.63K. The position accounts for ﹤0.01% of the portfolio, ranked #2468.

CoreCap Advisors first reported a position in REPL in Q3 2025 and has held it in 4 quarters since. 16 funds tracked by Wall St. Rank hold REPL as of Q2 2026.

  • CoreCap Advisors held 238 shares of Replimune Group worth $2.63K as of Q2 2026.
  • CoreCap Advisors bought 236 Replimune Group shares in Q2 2026, an estimated $1.44K.
  • Replimune Group made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #2468 holding.
  • CoreCap Advisors first reported a position in Replimune Group in Q3 2025 and has held it in 4 quarters since.
  • 16 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.